{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:12:11Z","timestamp":1789827131454,"version":"4.0.1"},"reference-count":20,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Technology"],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To review the efficacy, safety, and tolerability of tradipitant for the prevention of vomiting induced by motion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>A literature search was conducted through PubMed using the following terms: tradipitant, motion sickness, Nereus, and neurokinin-1 (NK-1) receptor antagonist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection and Data Extraction:<\/jats:title>\n                    <jats:p>Articles describing the pharmacology, pharmacokinetics, efficacy, safety, and\/or tolerability of tradipitant were included in this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>Tradipitant is a NK-1 receptor antagonist shown to reduce vomiting due to motion. Clinical trials have demonstrated improvements in the occurrence of vomiting as well as multiple episodes of vomiting secondary to various sea conditions. Common adverse effects associated with this agent include fatigue, somnolence, and headache when taken as a single-dose treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Scopolamine and first-generation antihistamines are commonly used to prevent and treat motion sickness; however, their use is limited by their significant adverse effect profiles. Tradipitant, the newest agent approved for motion sickness, provides clinicians with an additional treatment option for this common condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/87551225261486011","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:36:16Z","timestamp":1789644976000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Tradipitant for Motion Sickness: Expanding the Therapeutic Landscape of NK\u2081 Receptor Antagonists"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-2906","authenticated-orcid":false,"given":"Erin","family":"St. Onge","sequence":"first","affiliation":[{"name":"Department of Pharmacy Education and Practice, University of Florida College of Pharmacy, Orlando, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-5263","authenticated-orcid":false,"given":"Adonice","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Education and Practice, University of Florida College of Pharmacy, Gainesville, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"Takov V Tadi P. Motion sickness. StatPearls Publishing. Published 2023. Accessed April 17 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539706\/?report=printable"},{"key":"e_1_3_2_3_2","unstructured":"Priesol AJ. Motion sickness. In: Deschler DG Hussain Z eds. Up to Date. Wolters Kluwer. Published February 2026. Accessed April 17 2026. www.uptodate.com"},{"key":"e_1_3_2_4_2","unstructured":"Centers for Disease Control Prevention. CDC Yellow Book 2026: Health Information for International Travel. Oxford University Press. Published 2025. Accessed April 17 2026. https:\/\/www.cdc.gov\/yellow-book\/hcp\/travel-air-sea\/motion-sickness.html"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Polymeropoulos VM Czeisler ME Gibson MM et al. Tradipitant in the treatment of motion sickness: a randomized double-blind placebo-controlled study. Front Neurol. 2020;11:563373. https:\/\/doi.org\/10.3389\/fneur.2020.563373","DOI":"10.3389\/fneur.2020.563373"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Polymeropoulos VM Kiely L Bushman ML et al. Motion syros: tradipitant effective in the treatment of motion sickness; a multicenter randomized double-blind placebo-controlled study. Front Neurol. 2025;16:1550670. https:\/\/doi.org\/10.3389\/fneur.2025.1550670","DOI":"10.3389\/fneur.2025.1550670"},{"key":"e_1_3_2_7_2","unstructured":"Vanda Pharmaceuticals Inc. Nereus package insert. Published 2025. Accessed April 17 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/220152Orig1s000lbl.pdf"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Carlin JL Lieberman VR Dahal A et al. Efficacy and safety of tradipitant in patients with diabetic and idiopathic gastroparesis in a randomized placebo-controlled trial. Gastroenterology. 2021;160(1):76-87. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.029","DOI":"10.1053\/j.gastro.2020.07.029"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Carlin JL Polymeropoulos C Camilleri M et al. The efficacy of tradipitant in patients with diabetic and idiopathic gastroparesis in a phase 3 randomized placebo-controlled clinical trial. Clin Gastroenterol Hepatol. 2024;22(12):2506-2516. https:\/\/doi.org\/10.1016\/j.cgh.2024.01.005","DOI":"10.1016\/j.cgh.2024.01.005"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Czeisler M\u00c9 Pruski JM Wang P et al. Validation of the motion sickness severity scale: secondary analysis of a randomized double-blind placebo-controlled study of a treatment for motion sickness. PLOS ONE. 2023;18(1):e0280058. https:\/\/doi.org\/10.1371\/journal.pone.0280058","DOI":"10.1371\/journal.pone.0280058"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17065"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00164.2002"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016488809119444"},{"issue":"7","key":"e_1_3_2_14_2","first-page":"631","article-title":"P6 acupressure reduces symptoms of vection-induced motion sickness","volume":"66","author":"Hu S","year":"1995","unstructured":"Hu S, Stritzel R, Chandler A, Stern RM. P6 acupressure reduces symptoms of vection-induced motion sickness. Aviat Space Environ Med. 1995;66(7):631-634.","journal-title":"Aviat Space Environ Med"},{"issue":"4","key":"e_1_3_2_15_2","first-page":"91","article-title":"Acupressure relieves the symptoms of motion sickness and reduces abnormal gastric activity","volume":"7","author":"Stern RM","year":"2001","unstructured":"Stern RM, Jokerst MD, Muth ER, Hollis C. Acupressure relieves the symptoms of motion sickness and reduces abnormal gastric activity. Altern Ther Health Med. 2001;7(4):91-94.","journal-title":"Altern Ther Health Med"},{"issue":"8","key":"e_1_3_2_16_2","first-page":"776","article-title":"A double-blind placebo controlled evaluation of acupressure in the treatment of motion sickness","volume":"62","author":"Warwick-Evans LA","year":"1991","unstructured":"Warwick-Evans LA, Masters IJ, Redstone SB. A double-blind placebo controlled evaluation of acupressure in the treatment of motion sickness. Aviat Space Environ Med. 1991;62(8):776-778.","journal-title":"Aviat Space Environ Med"},{"issue":"3","key":"e_1_3_2_17_2","first-page":"227","article-title":"Efficacy of acupressure and acustimulation bands for the prevention of motion sickness","volume":"75","author":"Miller KE","year":"2004","unstructured":"Miller KE, Muth ER. Efficacy of acupressure and acustimulation bands for the prevention of motion sickness. Aviat Space Environ Med. 2004;75(3):227-234.","journal-title":"Aviat Space Environ Med"},{"key":"e_1_3_2_18_2","unstructured":"Scopolamine: Clinical Pharmacology [Database online]. Gold Standard Inc.; 2026. Accessed May 7 2026. Clinicalpharmacology.com"},{"key":"e_1_3_2_19_2","unstructured":"Diphenhydramine: Clinical Pharmacology [Database online]. Gold Standard Inc.; 2026. Accessed May 7 2026. Clinicalpharmacology.com"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"By the 2023 American Geriatrics Society Beers\u00ae Criteria Update Expert Panel. American Geriatrics Society 2023 Updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. https:\/\/doi.org\/10.1111%2Fjgs.18372","DOI":"10.1111\/jgs.18372"},{"key":"e_1_3_2_21_2","unstructured":"Drugs.com. Tradipitant alternatives compared. Accessed April 29 2026. https:\/\/www.drugs.com\/compare\/tradipitant"}],"container-title":["Journal of Pharmacy Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/87551225261486011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/87551225261486011","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/87551225261486011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:52:46Z","timestamp":1789825966000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/87551225261486011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":20,"alternative-id":["10.1177\/87551225261486011"],"URL":"https:\/\/doi.org\/10.1177\/87551225261486011","relation":{},"ISSN":["8755-1225","1549-4810"],"issn-type":[{"value":"8755-1225","type":"print"},{"value":"1549-4810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"87551225261486011"}}